Cumberland Pharmaceuticals (CPIX) Current Leases (2019 - 2026)

Cumberland Pharmaceuticals has disclosed Current Leases across 8 years of filings, most recently posting $485162.0 for Q1 2026.

• Current Leases for Q1 2026 came in at $485162.0, up 30.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $485162.0 (up 30.74% YoY), and the FY2025 annual result was $467774.0, up 31.21% from the prior year.
• Current Leases came in at $485162.0 for Q1 2026 at Cumberland Pharmaceuticals, up from $467774.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $766488.0 in Q1 2022 to a low of $158369.0 in Q1 2023.
• The 5-year median for Current Leases is $371094.0 (2025), against an average of $378922.6.
• Across the five-year window, Current Leases tumbled 82.17% in 2022 and surged 128.73% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Current Leases stood at $172910.0 in 2022, then soared by 101.31% to $348092.0 in 2023, then increased by 2.42% to $356508.0 in 2024, then surged by 31.21% to $467774.0 in 2025, then grew by 3.72% to $485162.0 in 2026.
• The last three Current Leases figures came in at $485162.0 (Q1 2026), $467774.0 (Q4 2025), and $401445.0 (Q3 2025), per Business Quant data.